Clinical features associated with improvement of fatty liver disease

Internal Medicine Journal

Volumn 35, Issue 8, 2005, Pages 473-477

  Park, S H ^a   Kim, Byong Ik ^a   Kim, H J ^a   Kim, H ^a   Kim, S H ^a   Park, D I ^a   Cho, Y K ^a   Sung, I K ^a   Sohn, C I ^a   Jeon, W K ^a   Keum, D K ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Bodyweight; Fatty liver disease; Low density lipoprotein cholesterol

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; ECHOGRAPHY; FATTY LIVER; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; MALE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADULT; AGED; ALANINE TRANSAMINASE; ANALYSIS OF VARIANCE; BODY COMPOSITION; BODY MASS INDEX; CHOLESTEROL, LDL; COHORT STUDIES; CONFIDENCE INTERVALS; FATTY LIVER; FOLLOW-UP STUDIES; HUMANS; KOREA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROBABILITY; REMISSION, SPONTANEOUS; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER;

EID: 23844490756     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2005.00887.x     Document Type: Article

References (21)

1. Omagari K, Kadokawa Y, Masuda J, Egawa I, Sawa T, Hazama H et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol 2002; 17: 1098-105.
2. Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of non-alcoholic steatosis syndromes. Semin Liver Dis 2001; 21: 17-26.
3. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Non-alcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-19.
4. Clouston AD, Powell EE. Non-alcoholic fatty liver disease: is all the fat bad? Intern Med J 2004; 34: 187-91.
5. Yajima Y, Ohta K, Narui T, Abe R, Suzuki H, Ohtsuki M. Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast. Tohoku J Exp Med 1983; 139: 43-50.
6. Poehlman ET, Toth MJ, Gardner AW. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med 1995; 123: 673-5.
7. Tchernof A, Poehlman ET, Despres JP. Body fat distribution, the menopause transition, and hormone replacement therapy. Diabetes Metab 2000; 26: 12-20.
8. Mathews DR, Hoskers JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment of insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-19.
9. Chen QK, Chen HY, Huang KH, Zhong YQ, Han JA, Zhu ZH et al. Clinical features and risk factors of patients with fatty liver in Guangzhou area. World J Gastroenterol 2004; 10: 899-902.
10. McCullough AJ. Update on non-alcoholic fatty liver disease. J Clin Gastroenterol 2002; 34: 255-62.
11. Angelico F, Del Ben M, Conti R, Francioso S, Feole K, Maccioni D et al. Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases. J Gastroenterol Hepatol 2003; 18: 588-94.
12. Clark JM, Brancati FL, Diehl AM. Non-alcoholic fatty liver disease. Gastroenterology 2002; 122: 1649-57.
13. Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA et al. Clinical and histologic spectrum of non-alcoholic fatty liver disease associated with normal ALT values. Hepatology 2003; 37: 1286-92.
14. Younossi ZM, Diehl AM, Ong JP. Non-alcoholic fatty liver disease: an agenda for clinical research. Hepatology 2002; 35: 746-52.
15. Angulo P, Keach JC, Butts KP, Lindor KD. Independent predictors of liver fibrosis in patients with non-alcoholic steatohepatitis. Hepatology 1999; 30: 1356-62.
16. Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 1997; 27: 103-7.
17. Park HS, Kim MW, Shin ES. Effect of weight control on hepatic abnormalities in obese patients with fatty liver. J Korean Med Sci 1995; 10: 414-21.
18. Sanyal AJ. Treatment of non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2002; 17: S385-8.
19. Basaranoglu M, Acbay O, Sonsuz A. A controlled trial of gemfibrozil in the treatment of patients with non-alcoholic steatohepatitis. J Hepatol 1999; 31: 384.
20. Laurin J, Lindor KD, Crippin JS, Gossard A, Gores GJ, Ludwig J et al. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology 1996; 23: 1464-7.
21. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Zoli M, Mechionda N. Metformin in non-alcoholic steatohepatitis. Lancet 2001; 358: 893-4.